Moderna Shares Fall 8% in Premarket Trading
On August 27, 2026, Moderna's U. S. -listed shares dropped 8% in premarket trading, extending earlier losses. The decline reflects investor sentiment ahead of the market open, with no specific catalyst disclosed in the report.
On August 27, 2026, Moderna's U. S. -listed shares extended their decline in premarket trading, with the stock falling 8%.